Canaan Partners VII’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Canaan Partners VII’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,902,030	Closed	-$24.1M	–	6
2014 Q3	$24.1M	Hold	1,902,030	–	–	41.13%	1
2014 Q2	$32.4M	Hold	1,902,030	–	–	36.48%	2
2014 Q1	$25.6M	Hold	1,902,030	–	–	32.83%	2
2013 Q4	$24.3M	Buy	+1,902,030	New	+$20M	22.22%	3

Canaan Partners VII's DRTX Position: Q4 2014 in Review

Canaan Partners VII sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 1,902,030 shares — an estimated $24.1M sold.

Canaan Partners VII first reported a position in DRTX in Q4 2013 and held it in 4 quarters. The position peaked at $32.4M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Canaan Partners VII reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Canaan Partners VII sold 1,902,030 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $24.1M.
Canaan Partners VII first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 4 quarters.
Canaan Partners VII's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $32.4M in Q2 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Canaan Partners VII's 13F filing for Q4 2014, filed 18 Feb 2015.